ArticlePLoS computational biology2026
Eleven quick tips for Biomedical Federated Learning.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Modern statistical and machine learning techniques are effective at describing, testing hypotheses and making predictions from complex data. This effectiveness is strongly influenced by the volume and heterogeneity of available data. In many fields, including much of biomedicine, large centralized datasets are not available because of cost, privacy, regulatory or other restrictions. In these cases, smaller datasets are distributed across a large number of independent sites. Medical record data is a classic example of this challenge: the total number of patients may be large, but their records are distributed across many health systems and cannot easily be centralized. Federated learning (FL) is a machine learning paradigm that enables training and validation of a shared model in settings of decentralized data. FL can improve model accuracy and generalizability by increasing sample size, but has trade-offs ranging from operational complexity to data-privacy risks to the potential to introduce unexpected imbalances in model accuracy. We outline ten tips for successfully and sustainably implementing FL for Biomedical applications, ensuring both ethical data governance and improved model performance in sensitive domains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.